section of webpage -->

Atrial Fibrillation

Atrial fibrillation (commonly known as “A Fib”) is an irregular heart rhythm.  It is the most common heart rhythm condition (arrhythmia) in the United States, affecting more than 3 million people.  Each year, more than 5 million office visits are made for atrial fibrillation in this country.  Despite the increasing numbers of patients with this arrhythmia, there is growing confusion about how to treat atrial fibrillation amidst recent scientific and technological advancements.

Our heart rhythm specialists at MHVI are experts at educating patients and families and guiding them through an ever-expanding array of treatment options, including heart rhythm medications, blood thinning drugs, cardioversions, heart rhythm devices such as pacemakers, catheter ablation, and left atrial occlusion device.   The dedicated team of physicians, nurse practitioners, physician assistants, and nurse coordinators provide clinical expertise and partner with each patient to form a treatment plan that is individually tailored to suit his or her medical needs.

For more information on atrial fibrillation, please visit patient education resources from the Heart Rhythm Society and American College of Cardiology.

The left atrial appendage occlusion (Watchman TM) device allows patients to stop taking blood thinners (like warfarin, rivaroxaban, or apixaban) to prevent stroke, when they are not tolerated.  Learn more about the Watchman procedure.

Catheter ablation for atrial fibrillation (pulmonary vein isolation) can provide good control of symptoms when medications are not effective or tolerated.  Learn more about A Fib ablation.

AF / Watchman Contact

Robin Braun, RN
Watchman / Structural Heart Coordinator
Phone: 763­.236.­7459

© Metropolitan Heart Vascular Institute